Hypophosphatasia: A Novel Mutation Associated with an Atypical Newborn Presentation
Roger Esmel-VilomaraSusana HernándezAriadna Campos-MartorellEva Gonzalez-RocaDiego Yeste FernándezFélix CastilloPublished in: Journal of clinical research in pediatric endocrinology (2019)
Hypophosphatasia, a rare genetic disease affecting bone metabolism, is characterized by decreased activity of tissue non-specific alkaline phosphatase (TNAP). The gene encoding TNAP (ALPL) has considerable allelic heterogeneity, which could explain different degrees of enzyme activity resulting in a wide clinical variability. We report the case of a preterm newborn in whom a corneal opacity was detected at birth. Blood tests performed to investigate this finding showed low alkaline phosphatase concentrations. The corneal opacity disappeared within a week but alkaline phosphatase remained persistently low. With persistently decreased levels of alkaline phosphatase, upon suspicion of hypophosphatasia, plain radiography detected changes suggestive of rickets. Sequencing of the ALPL gene revealed a heterozygous variant that has not been described in the literature to date. Our patient’s condition may be an atypical neonatal form of the syndrome, with a mild phenotype, very different from the classic neonatal form, which can lead to severe skeletal disease and respiratory failure. However, it could also be an early diagnosis of the childhood form, which is associated with a better prognosis.
Keyphrases
- respiratory failure
- replacement therapy
- single cell
- genome wide
- case report
- copy number
- early onset
- extracorporeal membrane oxygenation
- optical coherence tomography
- systematic review
- gestational age
- wound healing
- mechanical ventilation
- dna methylation
- preterm birth
- low birth weight
- magnetic resonance imaging
- cataract surgery
- clinical trial
- image quality
- drug induced